Table 2 Comparison of surgical outcomes among various subtypes of GH- producing pituitary adenoma
Variables | Single Staining n = 48 (%67.6) | Dual Staining n = 23(%32.4) | Total n = 71(100%) | ||
|---|---|---|---|---|---|
Densely granulated n = 34 (%47.9) | Sparsely granulated n = 14 (%19.7) | Total n = 48 (%67.6) |  |  | |
Random GH levels, ng/ml (IQR) †| 1.3(0.7–2.5) | 1.45(0.95–6.62) | 1.3(0.7–3.5) | 1.69(0.85–3.22) | 1.5(0.7,-3.5) |
Median follow-up, month (IQR) | 12(6,24) | 12(6,15) | 12(6,24) | 12(6,24) | 12(6,24) |
Hypopituitarism, n (%) | |||||
 Central hypogonadism | 15(44.1) | 9(64.3) | 24(50) | 9(39.1) | 33(46.5) |
 Diabetes insipidus | 15(44.1) | 7(50.0) | 22(45.8) | 9(39.1) | 31(43.7) |
 Central hypothyroidism | 9(26) | 7(50) | 16(33) | 6(26) | 22(30) |
 Central adrenal insufficiency | 3(8.8) | 2(14.3) | 5(10.4) | 1(4.3) | 6(8.5) |
Cerebrospinal fluid leak, n (%) | 3(8.8) | 3(21.4) | 6(12.5) | 0(0) | 6(8.5) |
Meningitis, n (%) | 0(0) | 1(7.1) | 1(2.1) | 0(0) | 1(1.4) |
Focal neurological deficit, n (%) | 0(0) | 0(0) | 0(0) | 0(0) | 0(0) |